InnovAge Holding Corp. Capital Expenditures
InnovAge Holding Corp. (INNV) reported Capital Expenditures of $14.31 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-09-09
- InnovAge Holding Corp. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $4.27M.
- InnovAge Holding Corp. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $3.60M, a 24.28% increase year-over-year.
- InnovAge Holding Corp. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $2.36M, a 75.95% increase year-over-year.
- InnovAge Holding Corp. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $4.08M, a 85.32% increase year-over-year.
- InnovAge Holding Corp. payments to acquire property, plant, and equipment for fiscal 2026 was $14.31M, a 128.47% increase from fiscal 2025.
- InnovAge Holding Corp. payments to acquire property, plant, and equipment for fiscal 2025 was $6.26M, a 20.86% decline from fiscal 2024.
- InnovAge Holding Corp. payments to acquire property, plant, and equipment for fiscal 2024 was $7.91M, a 66.11% decline from fiscal 2023.
- InnovAge Holding Corp. payments to acquire property, plant, and equipment for fiscal 2023 was $23.35M, a 38.92% decline from fiscal 2022.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $7.87M derived: sum of 2 quarters · filed 2026-09-09 | $10.23M derived: sum of 3 quarters · filed 2026-09-09 | $14.31M 10-K · filed 2026-09-09 |
| 2026-03-31 | $3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $5.97M derived: sum of 2 quarters · filed 2026-05-08 | $10.04M 10-Q · filed 2026-05-08 | $9.86M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | $2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $6.44M 10-Q · filed 2026-02-03 | $6.26M derived: sum of 3 quarters · filed 2026-09-09 | $9.16M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | $4.08M 10-Q · filed 2025-11-04 | $3.90M derived: sum of 2 quarters · filed 2026-09-09 | $6.80M derived: sum of 3 quarters · filed 2026-09-09 | $8.14M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | -$179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $2.72M derived: sum of 2 quarters · filed 2026-09-09 | $4.06M derived: sum of 3 quarters · filed 2026-09-09 | $6.26M 10-K · filed 2026-09-09 |
| 2025-03-31 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $4.24M derived: sum of 2 quarters · filed 2026-05-08 | $6.44M 10-Q · filed 2026-05-08 | $9.75M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $3.54M 10-Q · filed 2026-02-03 | $6.85M derived: sum of 3 quarters · filed 2026-02-03 | $7.30M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | $2.20M 10-Q · filed 2025-11-04 | $5.50M derived: sum of 2 quarters · filed 2025-11-04 | $5.96M derived: sum of 3 quarters · filed 2025-11-04 | $7.54M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | $3.76M derived: sum of 2 quarters · filed 2025-09-09 | $5.34M derived: sum of 3 quarters · filed 2025-09-09 | $7.91M 10-K · filed 2025-09-09 |
| 2024-03-31 | $452.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06 | $2.04M derived: sum of 2 quarters · filed 2025-05-06 | $4.61M 10-Q · filed 2025-05-06 | $8.63M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-04 | $4.16M 10-Q · filed 2025-02-04 | $8.18M derived: sum of 3 quarters · filed 2025-02-04 | $12.88M derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | $2.57M 10-Q · filed 2024-11-05 | $6.60M derived: sum of 2 quarters · filed 2024-11-05 | $11.29M derived: sum of 3 quarters · filed 2024-11-05 | $18.26M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | $8.72M derived: sum of 2 quarters · filed 2024-09-10 | $15.69M derived: sum of 3 quarters · filed 2024-09-10 | $23.35M 10-K · filed 2024-09-10 |
| 2023-03-31 | $4.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-07 | $11.66M derived: sum of 2 quarters · filed 2024-05-07 | $19.33M 10-Q · filed 2024-05-07 | $37.43M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $6.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-06 | $14.63M 10-Q · filed 2024-02-06 | $32.73M derived: sum of 3 quarters · filed 2024-02-06 | $41.19M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | $7.67M 10-Q · filed 2023-11-07 | $25.76M derived: sum of 2 quarters · filed 2023-11-07 | $34.22M derived: sum of 3 quarters · filed 2023-11-07 | $42.86M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $18.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | $26.56M derived: sum of 2 quarters · filed 2023-09-12 | $35.20M derived: sum of 3 quarters · filed 2023-09-12 | $38.24M 10-K · filed 2023-09-12 |
| 2022-03-31 | $8.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-09 | $17.10M derived: sum of 2 quarters · filed 2023-05-09 | $20.14M 10-Q · filed 2023-05-09 | $23.60M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $8.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | $11.68M 10-Q · filed 2023-02-07 | $15.14M derived: sum of 3 quarters · filed 2023-02-07 | $17.76M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | $3.04M 10-Q · filed 2022-11-08 | $6.50M derived: sum of 2 quarters · filed 2022-11-08 | $9.12M derived: sum of 3 quarters · filed 2022-11-08 | $15.95M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $6.08M derived: sum of 2 quarters · filed 2022-09-13 | $12.91M derived: sum of 3 quarters · filed 2022-09-13 | $17.54M 10-K · filed 2022-09-13 |
| 2021-03-31 | $2.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-10 | $9.45M derived: sum of 2 quarters · filed 2022-05-10 | $14.08M 10-Q · filed 2022-05-10 | $16.84M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $6.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-09 | $11.46M 10-Q · filed 2022-02-09 | $14.22M derived: sum of 3 quarters · filed 2022-02-09 | |
| 2020-09-30 | $4.63M 10-Q · filed 2021-11-09 | $7.38M derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | $11.84M 10-K · filed 2021-09-23 | ||
| 2020-03-31 | $9.09M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |